| Term 
 | Definition 
 
        | prokinetic agent--dopamine D2 receptor antagonist and partial 5-HT agonist (gastroparesis, reflux esophagitis, antiemetic) |  | 
        |  | 
        
        | Term 
 
        | sulfasalazine (azulfidine) |  | Definition 
 
        | topical aminosalicylate, immunosuppresive (IBD, RA-non biological DMARD) |  | 
        |  | 
        
        | Term 
 
        | methotrexate (trexall, rheumatrex, folex) |  | Definition 
 
        | antimetabolite--dihydrofolate reductase inhibitor, signal 3 inhibitor both B and T cells (chronic severe or steroid-resistant IBD, RA-nonbiologic DMARD, leukemia, tumors) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | monoclonal antibody against TNF alpha (Crohn's, RA-biologic DMARD) |  | 
        |  | 
        
        | Term 
 
        | acetyl salicylic acid (aspirin) |  | Definition 
 
        | irreversibly inhibits COX1 and COX2 (analgesic, antipyretic, antiinflammatory, antirheumatic) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | COX1/COX2 inhibitor (analgesic, antiinflammatory, weak antipyretic) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | COX1/COX2 inhibitor (rheumatoid arthritis, osteoarthritis, tocolytic--suppresses premature labor) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | COX1/COX2 inhibitor (rheumatoid/osteoarthritis, analgesia/dysmenorrhea) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | COX1/COX2 inhibitor (rheumatoid/osteoarthritis, juvenile RA) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | COX1/COX2 inhibitor (moderately severe acute pain, NOT for OA or RA) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | COX1/COX2 inhibitor (RA, OA, analgesia, dysmenorrhea, fever) |  | 
        |  | 
        
        | Term 
 
        | naproxen (anaprox, aleve) |  | Definition 
 
        | COX1/COX2 inhibitor (RA, juvenile RA, OA, analgesia, dysmenorrhea) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | COX1/COX2 inhibitor (RA, OA, analgesia, dysmenorrhea) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | COX1/COX2 inhibitor (RA, OA) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | COX1/COX2 inhibitor (RA, OA) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | COX1/more COX2 inhibitor (OA) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | COX1/more COX2 inhibitor (RA,OA) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | COX2 inhibitor (RA, OA, dysmenorrhea, acute pain, familial adenomatous polyposis) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | analgesia from weak COX1/COX2 inhibition and COX3 inhibition in CNS, antipyresis by action on hypothalamic heat-regulating center (antipyretic, analgesic, OA) |  | 
        |  | 
        
        | Term 
 
        | hydroxychloroquine sulfate (plaquenil) |  | Definition 
 
        | non biologic DMARD (RA, lupus, antimalarial) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | non biologic DMARD, dihydroorotate dehydrogenase inhibitor--inhibits pyrimidine synth. (RA) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | biologic DMARD--anti TNF alpha and beta (RA, Juvenile RA) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | glucocorticoid-inhibits phospholipase A2 and COX2 (allergies, hematologic disorders, hepatic/renal disease, collagen disorders) |  | 
        |  | 
        
        | Term 
 
        | methyprednisolone (medrol) |  | Definition 
 
        | glucocorticoid-inhibits phospholipase A2 and COX2 (allergies, hematologic disorders, hepatic/renal disease, collagen disorders) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | NSAID (acute gout attack) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | NSAID (acute gout attack, migraine) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | injectable NSAID (acute gout attack) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | binds tubulin inhibiting gout specific inflammation (acute gout attack) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | xanthine oxidase inhibitor--decreasing formation of uric acid (prophylaxis for gout in patients who are producing excess uric acid or have existing kidney stones) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | inhibits secretion and reabsorption of uric acid (prophylaxis of gout in patients who do not normally excrete large amounts of uric acid in the urine) |  | 
        |  | 
        
        | Term 
 
        | ergotamine tartrate (ergomar, ercaf, cafergot) |  | Definition 
 
        | 5-HT1B receptor agonist--vasoconstriction and reduce neurogenic inflammation (2nd line therapy for acute treatment of migraine) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1st gen triptan serotonin derivative--vasoconstriction and reduce neurogenic inflammation (1st line treatment for migraine) |  | 
        |  | 
        
        | Term 
 
        | zolmitriptan (zomig, zomig ZMT) |  | Definition 
 
        | 2nd gen triptan serotonin derivative--vasoconstriction and reduce neurogenic inflammation, centrally inhibits pain transmission in trigeminal nucleus (1st line treatment for migraine) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | dopamine antagonist (acute migraine, antiemetic) |  | 
        |  | 
        
        | Term 
 
        | prochlorperazine (compazine) |  | Definition 
 
        | dopamine antagonist (acute migraine, antiemetic) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | B blocker (prophylaxis of migraine, anxiolytic--stage fright) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | antimetabolite, signal 3 inhibitor of mainly T cells (chronic severe or steroid-resistant IBD, RA, renal transplant) |  | 
        |  | 
        
        | Term 
 
        | methotrexate (trexall, rheumatrex, folex) |  | Definition 
 
        | antimetabolite--dihydrofolate reductase inhibitor, signal 3 inhibitor both B and T cells (chronic severe or steroid-resistant IBD, RA-nonbiologic DMARD, leukemia, tumors) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | glucocorticoid-inhibits phospholipase A2 and COX2 (allergies, hematologic disorders, hepatic/renal disease, collagen disorders) |  | 
        |  | 
        
        | Term 
 
        | methyprednisolone (medrol) |  | Definition 
 
        | glucocorticoid-inhibits phospholipase A2 and COX2 (allergies, hematologic disorders, hepatic/renal disease, collagen disorders) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | signal 3 inhibitor, inhibits B and T cells (RA, leukemia, tumors) |  | 
        |  | 
        
        | Term 
 
        | mycophenolate mofetil (cellcept) |  | Definition 
 
        | signal 3 inhibitor of B and T cells-inhibits purine synthesis (renal/liver/heart transplant rejection) |  | 
        |  | 
        
        | Term 
 
        | cyclosporine (sandimmune) |  | Definition 
 
        | signal 1 inhibitor of T cells-calcineurin phosphatase inhibitor (renal/liver/heart transplant rejection, RA) |  | 
        |  | 
        
        | Term 
 
        | muromonab-CD3 (orthoclone OKT3) |  | Definition 
 
        | murine Ig-signal 1 inhibitor of T cells-CD3 receptor antagonist (renal/liver/pancreas/heart transplant rejection) |  | 
        |  | 
        
        | Term 
 
        | Rho immune globulin (RhoGam) |  | Definition 
 
        | human Ig (erythroblastosis fetalis) |  | 
        |  | 
        
        | Term 
 
        | immune globulin (gammagard) |  | Definition 
 
        | human IgG, IgM (hypogammaglobulinemia, prophylaxis in HIV patients) |  | 
        |  | 
        
        | Term 
 
        | interferon beta-1b (betaseron) |  | Definition 
 
        | antiviral/immunoregulator (relapsing-remitting multiple sclerosis) |  | 
        |  | 
        
        | Term 
 
        | interferon gamma-1b (actimmune) |  | Definition 
 
        | phagocyte activator, antibody-dependent cellular cytotoxicity (chronic granulomatous disease) |  | 
        |  | 
        
        | Term 
 
        | spironolactone (aldactone) |  | Definition 
 
        | diuretic (antihypertensive, CHF) |  | 
        |  | 
        
        | Term 
 
        | hydrocortisone (cortisol, cortaid) |  | Definition 
 
        | short acting glucocorticoid (adrenocortical insufficiency; anti-inflammatory) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | intermediate acting glucocorticoid (allergies, autoimmune disorders) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | intermediate acting glucocorticoid (aersolized, topical) |  | 
        |  | 
        
        | Term 
 
        | dexamethasone (baycadron) |  | Definition 
 
        | long acting glucocorticoid (systemic anti-inflammatory) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | mineralcorticoid (adrenalcortical insufficiency--addison's disease) |  | 
        |  | 
        
        | Term 
 
        | spironolactone (aldactone) |  | Definition 
 
        | competitive aldosterone antagonist (edema, hypertension, CHF) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | synthetic ACTH (diagnostic test for adrenocortical insufficiency) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 11 B-hydroxylase inhibitor--inhibits cortisol and aldosterone production (Cushing's) |  | 
        |  |